METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer: targeted radiation therapy trial launches
Disease control Recruiting nowThis study tests a drug called 177Lu-PSMA-617 in people with advanced liver cancer that has spread. The drug delivers radiation directly to cancer cells that have a specific marker (PSMA). The trial will enroll 10 adults whose cancer has worsened after standard treatment, to see …
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated May 17, 2026 00:59 UTC
-
New hope for advanced cancers? first human trial of ERX-315 begins
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called ERX-315 in 15 adults with advanced solid tumors (such as breast, ovarian, or pancreatic cancer) that have stopped responding to approved therapies. The main goal is to find safe doses and watch for side effects, not to …
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: EtiraRx Australia Pty Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New immune cell therapy targets Hard-to-Treat liver cancer
Disease control Recruiting nowThis study tests a new treatment called ECT204 for adults with advanced liver cancer that has not responded to at least two other therapies. The treatment uses specially engineered immune cells to attack cancer cells. The goal is to find a safe dose and see if it can shrink tumor…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Engineered immune cells take on Hard-to-Treat liver cancer
Disease control Recruiting nowThis study tests a new treatment for adults with advanced liver cancer that has not responded to standard therapies. The treatment uses specially designed immune cells from a donor to target two proteins on cancer cells. The goal is to see if the treatment is safe and can shrink …
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 14, 2026 12:02 UTC